JRK is a positive regulator of β-catenin transcriptional activity commonly overexpressed in colon, breast and ovarian cancer Academic Article uri icon

authors

  • Pangon, L
  • Ng, I
  • Giry-Laterriere, M
  • Currey, N
  • Morgan, A
  • Benthani, F
  • Tran, PN
  • Al-Sohaily, S
  • Segelov, E
  • Parker, BL
  • Cowley, MJ
  • Wright, DC
  • St Heaps, L
  • Carey, L
  • Rooman, I
  • Kohonen-Corish, MRJ

publication date

  • June 2016